Alteogen Inc. Alteogen Inc.

Alteogen Inc.

196170

Pozycja w akcjach #1844
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters,... ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology. It is also involved in the development of ALT-P7, a targeted breast/gastric cancer drug that is in the Phase I clinical trial; ALT-Q5, an antibody-drug conjugate (ADC) for the treatment of ovarian cancer based on its NexMab ADC technology; and ALT-LS2, a SC (subcutaneous) formulation of trastuzuamb for the treatment of breast and gastric cancer. The company has a strategic alliance with Kissei Pharmaceutical for the development of ALT-L9, a biosimilar of Eylea (Aflibercept) which is currently under Phase 1 trial; Cristalia for the development of ALT-L2, a biosimilar of Herceptin (Trastuzumab), a monoclonal antibody for the treatment of breast cancer, which is in the Phase II clinical trial; and Biogen Inc. to develop subcutaneous (SC) formulations of biologics utilizing ALT-B4. ALTEOGEN Inc. was founded in 2008 and is headquartered in Daejeon, South Korea.
Cena akcji
$165.61
Kapitalizacja rynkowa
$11.53B
Zmiana (1 dzień)
4.13%
Zmiana (1 rok)
-46.48%
Kraj
KR
Handel Alteogen Inc. (196170)

Kategoria

Healthcare
Historia podziałów akcji dla Alteogen Inc. (196170)
Akcje Alteogen Inc. (symbol: 196170) przeszły łącznie 5 podziałów.
Najnowszy podział miał miejsce Aug 05, 2026.
Jedna akcja 196170 kupiona przed Dec 07, 2017 odpowiada dziś 1.2037037037037 akcjom 196170.
Lista podziałów akcji
Rok Podział Mnożnik Skumulowany mnożnik
2026-08-05 13:10 x1.3 x1.2037037037037
2022-10-25 6:5 x1.2 x0.92592592592593
2021-03-24 5:4 x1.25 x0.77160493827161
2020-07-23 10:9 x1.1111111111111 x0.61728395061728
2017-12-07 5:9 x0.55555555555556 x0.55555555555556
Podziały akcji dla podobnych firm lub konkurencji
Firma Liczba podziałów akcji Skumulowany mnożnik Kraj
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL